RG
Robin Gao
Principal at Sixty Degree Capital
Canada
Overview
Robin Gao is a Healthcare VC at Sixty Degree Capital in Canada, with a background in corporate development at Focal Healthcare and business development at AmacaThera. With experience in investment strategies and financial modeling, Robin specializes in healthcare sectors such as pharmaceuticals, digital health, and health IT, focusing on Series B, Series A, and Seed stage companies.
Work Experience
Principal
2022 - Current
Biotech / Healthcare venture investment. Exits: Schrödinger, Monte Rosa, Cincor Pharma, Arcellx, Northern Biologics, Engage Therapeutics, Turnstone Biologics, Korro Bio, Contineum Therapeutics.
Associate
2019 - 2022
Corporate Development
2018 - 2019
Focal Healthcare is a medical device company developing MRI/TRUS Fusion targeted guidance system for prostate cancer biopsy and therapy.
Business Development
2018 - 2018
AmacaThera is a biotech company developing and commercializing a unique, injectable hydrogel platform technology for a wide range of medical applications.
Pre-Clinical Discovery
2016 - 2016
Preclinical ADMET studies to screen neurodegenerative disease drug candidates.
Teaching Assistant
2016 - 2016
CHMC42 Organic Synthesis with laboratory component
Undergraduate Thesis Student
2015 - 2016
Novel MRI contrast agent
Research Assistant
2014 - 2014
HIV vaccine